[[Publications List]](publications.md)  [[CABS Ranked]](ref.md)

# Clinical Trials

_Clinical trials coordinated statistically as Senior Statistician at the Hellenic Cooperative Oncology Group (HeCOG)_

---

## Lung Cancer

**[5]** ClinicalTrials.gov Identifier: **[NCT03568097](https://clinicaltrials.gov/study/NCT03568097)** - PAVE: Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung Cancer
   * Mountzios, G., Papadopoulou, K., Korfiatis, N., Goussia, A., Samantas, E., Aravantinos, G., Christopoulou, A., Spathas, N., Fountzilas, E., Psyrri, A., Koliou, G.-A., Meditskou, S., Kosmas, E., Bobos, M., Charchanti, A.V., Vamvakaris, I., Koumarianou, A., Bafaloukos, D., Kosmidis, P.A., Fountzilas, G., & Linardou, H. (2025). Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis. *European Journal of Cancer*, 228, 115660.

**[4]** ClinicalTrials.gov Identifier: **[NCT05372081](https://clinicaltrials.gov/study/NCT05372081)** - SNF-CLIMEDIN: Digital support and intervention in patients with advanced NSCLC
   * Kosmidis, P.A., Kosmidis, T., Papadopoulou, K., Korfiatis, N., Vozikis, A., Lampaki, S., Psyrri, A., Fountzilas, E., Christopoulou, A., Samantas, E., Vagionas, A., Mountzios, G.S., Gkoumas, G., Tsoukalas, N., Athanasiadis, I., Bafaloukos, D., Panopoulos, C.G., Koufaki, M.I., Fountzilas, G., & Linardou, H. (2025). SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLCâ€”Final results. *Journal of Clinical Oncology*, 43(16_suppl), 1515-1515.

---

## Colorectal Cancer

**[3]** ClinicalTrials.gov Identifier: **[NCT03311750](https://clinicaltrials.gov/study/NCT03311750)** - A-REPEAT: Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer
   * Sgouros, J., Eliades, A., Papadopoulou, K., Korfiatis, N., Papamichael, D., Fountzilas, E., Tsolaki, E., Achilleos, A., Tsangaras, K., Loizides, C., Oikonomopoulos, G., Makatsoris, T., Kypri, E., Ioannides, M., Koumbaris, G., Fountzilas, G., Patsalis, P.C., & Pentheroudakis, G. (2025). Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping. *ESMO Gastrointestinal Oncology*, 7, 100120.

---

## Prostate Cancer

**[2]** ClinicalTrials.gov Identifier: **[NCT02512458](https://clinicaltrials.gov/study/NCT02512458)** - CabaBone: Cabazitaxel in patients with castration-resistant prostate cancer and osseous metastases
   * Liontos, M., Goussia, A., Korfiatis, N., Papadopoulou, K., Kanellis, G., Visvikis, A., Petrakis, G., Tsiatas, M., Fountzilas, E., Samantas, E., Fountzilas, G., & Efstathiou, E. (2025). The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer: A Hellenic Cooperative Oncology Group Phase II Study. *Clinical Genitourinary Cancer*, 23(1), 102253.

---

## Breast Cancer

**[1]** ClinicalTrials.gov Identifier: **[NCT04829890](https://clinicaltrials.gov/study/NCT04829890)** - Dose-dense sequential adjuvant chemotherapy in patients with resected high-risk breast cancer
   * Goussia, A., Dimitrakopoulos, F.I.D., Korfiatis, N., Koletsa, T., Batistatou, A., Kourea, H.P., Bobos, M., Papadopoulou, K., Charchanti, A.V., Bai, M., Tzaida, O., Petraki, K., Arapantoni-Dadioti, P., Psyrri, A., Gogas, H., Zagouri, F., & Fountzilas, G. (2025). Clinical outcomes and important prognostic biomarkers following dose-dense sequential adjuvant chemotherapy (dds-CT) in early breast cancer (eBC): Pooled-analysis of individual patient data. *ESMO Open*, 10.
